The main application for Thyroglobulin (Tg) testing is the post‑operative follow‑up of patients with differentiated thyroid carcinoma (DTC). Detectable levels of serum Tg after total thyroidectomy are indicative of persistent or recurrent DTC.1
Elecsys® Tg II
The power to offer more for differentiated thyroid cancer (DTC) management

The power to offer more for differentiated thyroid cancer (DTC) management

Excellent functional sensitivity and precision
Figure 1. Sensitivity of current automated Tg assays: Elecsys Tg II with best-in-class sensitivity. Source: Package inserts, 2017.
- Improved sensitivity comes with better precision in the range around the clinical cut-off and improved negative predictive value3
- Sensitive Tg assays can avoid TSH-stimulated Tg testing during follow-up, in low-risk patients1
- Patients with a basal Tg below the functional sensitivity of a sensitive Tg assay have a high chance of being free of disease2
- High quality patient results and accurate long-term monitoring
Excellent precision across the entire measuring range supports accurate results3
- Lot-to-lot consistency across all cobas® platforms allows a reliable long-term patient monitoring
- Elecsys® Tg II shows lower TgAb interference, compared to other assays1
- Higher sensitivity allows for potentially earlier detection of persistence or recurrence
Increasing concentrations of Tg (even at low concentrations) are an early and reliable indicator of recurrent disease1
- Treatment is usually more successful with early detection, as the tumor burden is lower1
* LoB = Limit of Blank; LoD = Limit of Detection; LoQ = Limit of Quantitation with a total allowable error of ≤20 %.